Biotechnology

Let's check to see what can be gleaned.

The medical research and device company announces positive results from its recent aortic valve surgical treatment trial.

Let's look at a couple of companies we have covered on these pages before.

In a red flag for investors, the charts show sellers are getting more aggressive with Sarepta.

BioScrip agrees to buy rival Option Care Enterprises, creating one of the largest independent home-therapy companies in the U.S.

The Internet of Things promises to merge the physical and data worlds together. This is why that's a good thing.

Strength in Apple and other FANG names are pluses, as are pockets of action in gold mining, cannabis, biotechnology and shipping.

Lannett rises after the drugmaker enters an agreement with two other pharmaceutical players to sell a generic form of Adderall.

Shares of Exact Sciences has been on the upswing, but the stock price of the cancer screening test firm may be vulnerable.

Insider purchases have tapered off from their frenzied pace in late 2018, but here are three names where such buying is evident.